Author Topic: Fast tracking AB-555 (elezanumab) fpr SCI, possibly MS  (Read 47 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9821
  • MS diagnosed 1980
  • Location: Pacific Northwest
Fast tracking AB-555 (elezanumab) fpr SCI, possibly MS
« on: October 14, 2020, 09:48:59 pm »

A short article entitled "AbbVie Gets Orphan Drug and Fast Track Status for Elezanumab" (from Pharmaceutical Technology, 9/29/20).  It is a potential drug for SCI (spinal cord injury) but there is some possibility that it might be useful for treating MS as well. According to the article,


Quote
Studies of elezanumab to treat spinal cord injuries, as well as multiple sclerosis and acute ischemic stroke, are under progress. The drug candidate is undergoing a Phase II clinical trial for SCI.


https://www.pharmaceutical-technology.com/news/abbvie-orphan-drug-elezanumab/
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
118 Views
Last post May 04, 2016, 06:07:28 pm
by agate
0 Replies
105 Views
Last post March 15, 2018, 04:11:33 pm
by agate
0 Replies
56 Views
Last post December 19, 2018, 09:44:14 pm
by agate
0 Replies
57 Views
Last post September 22, 2019, 03:12:00 pm
by agate
3 Replies
96 Views
Last post December 18, 2020, 09:47:39 pm
by agate